Cell Expansion Market Size & Growth Forecast 2027–2036, By Segments (Product, End-use, Cell Type, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Cell Expansion Market size was more than USD 28.7 billion in 2026 and is set to grow at a 12.45% CAGR between 2027 and 2036, surpassing USD 92.78 billion by 2036. The industry revenue for 2027 is estimated at USD 31.71 billion.
Get more details on this report
Request Free Sample ReportCell Expansion Market Intelligence Snapshot
Regional Market Dynamics
- North America held 41.34% share, supported by strong biopharmaceutical companies, advanced cell therapy research, established manufacturing infrastructure, and CRO/CDMO networks enabling efficient cell processing.
- Asia Pacific is projected at 14.34% CAGR, driven by expanding biotechnology base, rising cell therapy investment, growing research institutions, and increasing scale-up capacity for expansion technologies.
Segment Momentum
- Consumables captured 48.44% of the market in 2026 because cell expansion workflows require continuous replenishment of media, reagents, sera, and other single-use materials across research and production activities.
- Research Institutes are the fastest-growing end-use segment as more programs in stem cells, immunology, and disease modeling incorporate scalable cell expansion into routine laboratory and translational research workflows.
Market Expansion Drivers
- Increasing adoption of automated cell expansion systems improving biologics and cell therapy manufacturing efficiency.
- Growing demand for single-use systems reducing contamination risks in cell therapy production workflows.
- Rising investments in stem cell and gene therapy research accelerating scalable cell expansion platform development.
Leading Market Participants
- Leading companies in the cell expansion market include Thermo Fisher Scientific Inc. (United States), Cytiva (United States), Merck KGaA (Germany), Sartorius AG (Germany), Corning Incorporated (United States), STEMCELL Technologies Inc. (Canada), Miltenyi Biotec B.V. & Co. KG (Germany), Becton, Dickinson and Company (United States), Terumo Blood and Cell Technologies, Inc. (United States), Takara Bio Inc. (Japan).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 28.7 billion
- 2027 Estimated Market Size: USD 31.71 billion.
- Projected Market Size: USD 92.78 billion by 2036
- Growth Forecast: 12.45% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Consumables (Product) | Biopharmaceutical & Biotechnology Companies (End-use) | Mammalian (Cell Type) | Biopharmaceuticals (Application)
- Emerging Opportunity Segment: Instruments (Product) | Research Institutes (End-use) | Mammalian (Cell Type) | Vaccine Production (Application)
Market Growth Drivers and Industry Trends
Increasing adoption of automated cell expansion systems improving biologics and cell therapy manufacturing efficiency
Automation is becoming increasingly important in cell-based manufacturing, as the cell expansion market benefits from technologies that improve process consistency, scalability, and operational control. Automated systems can reduce manual handling requirements, standardize critical expansion steps, and support reproducible cell growth across development and manufacturing environments. Their integration into biologics and cell therapy workflows also enables manufacturers to manage complex processes with greater efficiency while reducing operator-dependent variability, particularly where production requires controlled and repeatable expansion of viable cells.
Growing demand for single-use systems reducing contamination risks in cell therapy production workflows
The growing emphasis on process safety and contamination control is encouraging manufacturers to adopt disposable components and closed processing approaches, supporting the cell expansion market across cell therapy production. Single-use systems can limit exposure to external contaminants by reducing the need for repeated cleaning and sterilization of processing equipment, while also simplifying changeover between manufacturing batches. These advantages are particularly relevant to sensitive cell-based workflows where maintaining cell viability and product integrity is critical, encouraging wider incorporation of single-use bioreactors, vessels, tubing, and related expansion equipment.
Rising investments in stem cell and gene therapy research accelerating scalable cell expansion platform development
Increasing investment in stem cell and gene therapy research is creating a stronger need for technologies capable of producing sufficient quantities of high-quality cells for research, clinical development, and manufacturing applications. The cell expansion market will be propelled by efforts to develop scalable platforms that can support cell proliferation while maintaining viability and desired cellular characteristics. As therapies progress from laboratory research toward larger-scale development, researchers and manufacturers require expansion systems that can accommodate increasing production requirements, standardized processes, and controlled culture conditions for complex cell-based applications.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing adoption of automated cell expansion systems improving biologics and cell therapy manufacturing efficiency | 2.00% | High | North America, Europe, Asia Pacific | High | Near Term |
| Growing demand for single-use systems reducing contamination risks in cell therapy production workflows | 1.70% | Moderate | North America, Asia Pacific | High | Mid Term |
| Rising investments in stem cell and gene therapy research accelerating scalable cell expansion platform development | 1.50% | High | Europe, North America | Medium | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the cell expansion market, accounting for a 41.34% share in 2026. The region’s leading position is supported by advanced biotechnology and life sciences infrastructure, strong research capabilities, and widespread adoption of cell-based technologies across biopharmaceutical development and regenerative medicine. Continued investment in cell and gene therapy research is increasing demand for reliable and scalable cell expansion solutions, while sophisticated laboratory facilities and established expertise in bioprocessing are facilitating the integration of advanced expansion technologies into research and production workflows.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to be the fastest-growing region, driven by expanding biopharmaceutical manufacturing capabilities, increasing research activity, and growing investment in biotechnology infrastructure. Rising demand for advanced therapeutic development is encouraging laboratories and manufacturers to adopt more efficient cell culture and expansion processes. Improvements in healthcare infrastructure, increasing scientific capabilities, and greater emphasis on domestic biotechnology production are also creating favorable conditions for broader adoption of cell expansion technologies.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Manufacturing BaseGermany emphasizes controlled bioprocessing environments and high-specification equipment for cell expansion workflows. The country’s focus on biomanufacturing quality and reproducibility supports demand for closed-system technologies and optimized cell culture media.
France 🇫🇷
Clinical Translation SupportFrance is aligning cell expansion demand with translational research and hospital-based cell therapy programs. The market in France shows growing interest in flexible systems that can bridge laboratory development with regulated clinical production environments.
Italy 🇮🇹
Research-Led Application BaseItaly’s cell expansion market is influenced by academic and early-stage therapeutic research, particularly in oncology and tissue engineering. Italian institutions are focusing on adaptable expansion platforms that support experimental workflows and pilot-scale production.
Japan 🇯🇵
Regenerative Therapy AlignmentJapan’s cell expansion market is closely tied to regenerative medicine applications, where process reliability and product quality remain critical. Japanese manufacturers are investing in specialized expansion systems to support stem cell therapies and personalized treatment development.
South Korea 🇰🇷
Contract Bioproduction FocusSouth Korea is strengthening its role in outsourced biologics manufacturing, driving demand for efficient cell expansion technologies. Local priorities center on increasing throughput, reducing contamination risks, and improving production flexibility for diverse therapeutic pipelines.
United States 🇺🇸
Bioprocess Scale-Up HubThe U.S. cell expansion market is shaped by high-volume biopharmaceutical manufacturing and increasing demand for advanced cell therapies. U.S.-based developers prioritize scalable expansion platforms, automation integration, and process consistency to support commercial-stage biologics production.
Segment Leadership and Growth Trends
Cell Expansion Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Consumables (Largest Segment) vs Instruments (Fastest-Growing Segment)
Consumables represented the largest share of the cell expansion market at 48.44% in 2026, reflecting their essential role in maintaining continuous cell expansion workflows. Culture media, vessels, reagents, and related consumable products are repeatedly required across laboratory and production processes, generating recurring demand. The increasing use of cell-based research and biopharmaceutical manufacturing is supporting greater consumption of specialized materials required for reliable and scalable cell expansion.
Instruments are the fastest-growing product segment, driven by increasing demand for automated and controlled cell expansion processes. Advanced instruments can improve process consistency, reduce manual intervention, and support the monitoring and management of cells during expansion. As cell-based applications become more sophisticated and production workflows move toward greater scalability and automation, demand for dedicated expansion instruments is strengthening.
End-use Segment Analysis: Biopharmaceutical & Biotechnology Companies (Largest Segment) vs Research Institutes (Fastest-Growing Segment)
Biopharmaceutical & biotechnology companies held the largest share of the cell expansion market, accounting for 49.08% in 2026, supported by extensive use of cell expansion technologies in biologic development, manufacturing, and advanced cell-based applications. These organizations require reproducible and scalable expansion processes to generate sufficient cell populations for research and production activities. Increasing development of biologics and other cell-dependent applications continues to reinforce demand from this end-use group.
Research institutes are the fastest-growing end-use segment, supported by expanding investigation into cell biology, regenerative medicine, disease modeling, and other cell-based research areas. Research environments require flexible expansion systems capable of supporting diverse experimental workflows and increasingly sophisticated cellular studies. Greater emphasis on understanding cellular behavior and developing new therapeutic approaches is encouraging research institutes to adopt advanced cell expansion technologies.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Consumables, Culture Flasks and Accessories, Instruments | Consumables | Instruments |
| End-use | Biopharmaceutical & Biotechnology Companies, Research Institutes, Cell Banks, Others | Biopharmaceutical & Biotechnology Companies | Research Institutes |
| Cell Type | Mammalian, Microbial, Others | Mammalian | Mammalian |
| Application | Biopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research, Others | Biopharmaceuticals | Vaccine Production |
Competitive Landscape and Market Positioning
Major players in the cell expansion market:
1. Thermo Fisher Scientific Inc. (United States)
2. Cytiva (United States)
3. Merck KGaA (Germany)
4. Sartorius AG (Germany)
5. Corning Incorporated (United States)
6. STEMCELL Technologies Inc. (Canada)
7. Miltenyi Biotec B.V. & Co. KG (Germany)
8. Becton Dickinson and Company (United States)
9. Terumo Blood and Cell Technologies Inc. (United States)
10. Takara Bio Inc. (Japan)
The cell expansion market is advancing through increasing adoption of regenerative medicine and cell-based therapies across healthcare applications. Manufacturers are developing scalable expansion systems, automated bioprocessing platforms, and optimized culture technologies to improve cell yield and consistency. Growing investment in advanced therapeutics is also driving innovation in the cell expansion market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (United States) | |||||||
| Cytiva (United States) | |||||||
| Merck KGaA (Germany) | |||||||
| Sartorius AG (Germany) | |||||||
| Corning Incorporated (United States) | |||||||
| STEMCELL Technologies Inc. (Canada) | |||||||
| Miltenyi Biotec B.V. & Co. KG (Germany) | |||||||
| Becton Dickinson and Company (United States) | |||||||
| Terumo Blood and Cell Technologies Inc. (United States) | |||||||
| Takara Bio Inc. (Japan). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| PL BioScience | Jul-25 | PL BioScience inaugurated a 1,200-square-meter facility in Germany to increase the production capacity of Human Platelet Lysate. This strategic infrastructure expansion is intended to address the growing demand for high-quality cell culture supplements, thereby bolstering the company’s commercial manufacturing capabilities for cell expansion and broader regenerative medicine applications. |
| MaxCyte | Jun-25 | MaxCyte entered a strategic collaboration with Ori Biotech to evaluate manufacturing workflows for autologous cell therapies. By utilizing CD19 CAR expression as a test system, the initiative seeks to optimize scalable cell engineering and expansion processes, aiming to enhance manufacturing efficiency and throughput for next-generation CAR-T and autologous therapeutic platforms. |
| FUJIFILM Irvine Scientific | Jan-25 | FUJIFILM Irvine Scientific partnered with Terumo Blood and Cell Technologies to integrate its PRIME-XV T Cell Expansion Media with the Quantum Flex Cell Expansion System. This collaboration is designed to enhance the consistency, reliability, and scalability of T-cell manufacturing processes, supporting more efficient and reproducible production of advanced cellular therapies. |
| Cytiva | Jun-24 | Cytiva introduced the Sefia next-generation cell therapy manufacturing platform to streamline the production of CAR-T and other cell-based therapies. The platform is engineered to improve cell processing efficiency and reduce overall manufacturing costs, providing a scalable solution for developers aiming to accelerate the commercialization of sophisticated cell expansion workflows. |
| Evotec | Apr-24 | Just-Evotec Biologics, a subsidiary of Evotec, announced a significant investment in a new facility to expand its continuous biomanufacturing capacity. This project focuses on scaling automated, advanced cell-based manufacturing technologies, reinforcing the company’s strategic commitment to high-capacity production infrastructure necessary for the development of next-generation cell and biologic therapeutics. |
| panCELLa | May-23 | panCELLa entered into a research agreement with BioCentriq to evaluate stem cell-derived Natural Killer (NK) cell expansion technology. By leveraging panCELLa’s genetically engineered feeder cells, the collaboration aims to improve the expansion rate, total yield, and potency of manufactured NK cells, representing a targeted approach to enhancing technical capabilities in cell therapy production. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Cell Expansion Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Scale of Cell Expansion | Research & Discovery Scale, Process Development Scale, Clinical/Translational Scale, Commercial Manufacturing Scale |
| Culture Mode | Adherent Culture, Suspension Culture, 3D Culture |
| Automation Level | Manual & Low-Automation Systems, Semi-Automated Systems, Fully Automated Systems |
Cell Expansion Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Cell Therapy Manufacturing Adoption Analysis |
|
| Automation and Closed-System Adoption Trends |
|
| Commercial Manufacturing Capacity Assessment |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market size of cell expansion?
What is the expected industry size of cell expansion by 2036?
How is automation transforming investment priorities in the cell expansion market?
Why are single-use technologies gaining strategic importance in cell expansion workflows?
Why are consumables the largest product segment in the cell expansion market?
Which end-use segment is expanding fastest in the cell expansion market?
Why does North America hold the largest share in the cell expansion market?
What is driving Asia Pacific’s rapid growth in cell expansion?
Which organizations are considered leaders in the cell expansion landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization